High-cost claims are a top concern for self-funded plans, and the drivers are evolving. Join us on June 4 to review the 2026 report and discuss:

• What’s driving large claims (top conditions and what’s shifting)
• What million-dollar+ claims mean for volatility and stop-loss planning
• Injectable drug trends to watch (including emerging ultra-high-cost therapies)

Speakers:

• Mike Huppert, VP, Actuarial & Risk Management, Sun Life U.S.
• Ryan Murphy, VP, Health Capabilities, Sun Life U.S.
• Miles Varn, Chief Medical Officer, Sun Life U.S.

Hosted by: Jennifer Collier, President of Health and Risk Solutions, Sun Life U.S.